{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T07:35:35Z","timestamp":1742974535592,"version":"3.40.3"},"reference-count":20,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780443186677"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/bs.irn.2023.06.001","type":"book-chapter","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T20:05:01Z","timestamp":1690488301000},"page":"179-184","source":"Crossref","is-referenced-by-count":0,"title":["Adenosine A2A signals and dystonia"],"prefix":"10.1016","author":[{"given":"Makio","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/bs.irn.2023.06.001_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/ene.13762","article-title":"Dystonia: Diagnosis and management","volume":"26","author":"Albanese","year":"2019","journal-title":"European Journal of Neurology: The Official Journal of the European Federation of Neurological Societies"},{"issue":"Pt 4","key":"10.1016\/bs.irn.2023.06.001_bib2","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/brain\/117.4.859","article-title":"The behavioural and motor consequences of focal lesions of the basal ganglia in man","volume":"117","author":"Bhatia","year":"1994","journal-title":"Brain"},{"issue":"11","key":"10.1016\/bs.irn.2023.06.001_bib3","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1136\/jnnp.2006.087908","article-title":"Parkinson\u2019s disease with camptocormia","volume":"77","author":"Bloch","year":"2006","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"5","key":"10.1016\/bs.irn.2023.06.001_bib4","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.3390\/ijms22052691","article-title":"A2A receptor dysregulation in dystonia DYT1 knock-out mice","volume":"22","author":"D\u2019Angelo","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"10","key":"10.1016\/bs.irn.2023.06.001_bib5","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0166-2236(97)01096-5","article-title":"Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia","volume":"20","author":"Ferr\u00e9","year":"1997","journal-title":"Trends in Neurosciences"},{"issue":"7","key":"10.1016\/bs.irn.2023.06.001_bib6","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/mds.25529","article-title":"The definition of dystonia: Current concepts and controversies","volume":"28","author":"Frucht","year":"2013","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"12","key":"10.1016\/bs.irn.2023.06.001_bib7","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1097\/00001756-199808240-00032","article-title":"Adenosine A2A receptors modify motor function in MPTP-treated common marmosets","volume":"9","author":"Kanda","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/bs.irn.2023.06.001_bib8","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.nbd.2017.08.007","article-title":"Abnormal striatal plasticity in a DYT11\/SGCE myoclonus dystonia mouse model is reversed by adenosine A2A receptor inhibition","volume":"108","author":"Maltese","year":"2017","journal-title":"Neurobiology of Disease"},{"issue":"2","key":"10.1016\/bs.irn.2023.06.001_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017338","article-title":"Adenosine A(2A) receptors measured with [C]TMSX PET in the striata of Parkinson\u2019s disease patients","volume":"6","author":"Mishina","year":"2011","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"10.1016\/bs.irn.2023.06.001_bib10","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.parkreldis.2020.09.025","article-title":"How do adenosine A2A receptors regulate motor function?","volume":"80","author":"Mori","year":"2020","journal-title":"Parkinsonism & Related Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2023.06.001_bib11","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.nbd.2010.03.003","article-title":"Dopamine D2 receptor dysfunction is rescued by adenosine A2A receptor antagonism in a model of DYT1 dystonia","volume":"38","author":"Napolitano","year":"2010","journal-title":"Neurobiology of Disease"},{"issue":"2","key":"10.1016\/bs.irn.2023.06.001_bib12","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/sj.bjp.0704268","article-title":"Effects of adenosine receptor agonists and antagonists in a genetic animal model of primary paroxysmal dystonia","volume":"134","author":"Richter","year":"2001","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.irn.2023.06.001_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105650","article-title":"Striatal synaptic dysfunction in dystonia and levodopa-induced dyskinesia","volume":"166","author":"Scarduzio","year":"2022","journal-title":"Neurobiology of Disease"},{"issue":"3","key":"10.1016\/bs.irn.2023.06.001_bib14","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/mds.26081","article-title":"Effect of neurostimulation on camptocormia in Parkinson\u2019s disease depends on symptom duration","volume":"30","author":"Schulz-Schaeffer","year":"2015","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"1","key":"10.1016\/bs.irn.2023.06.001_bib15","first-page":"75","article-title":"Camptocormia in Parkinson\u2019s disease: Definition, epidemiology, pathogenesis and treatment modalities","volume":"87","author":"Srivanitchapoom","year":"2016","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"443","key":"10.1016\/bs.irn.2023.06.001_bib16","article-title":"Safety and effectiveness of istradefylline as add-on therapy to levodopa in patients with Parkinson\u2019s disease: Final report of a post-marketing surveillance study in Japan","volume":"15","author":"Takahashi","year":"2022","journal-title":"Journal of the Neurological Sciences"},{"issue":"15","key":"10.1016\/bs.irn.2023.06.001_bib17","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1080\/14656566.2018.1518433","article-title":"Safety and effectiveness of istradefylline in patients with Parkinson\u2019s disease: Interim analysis of a post-marketing surveillance study in Japan","volume":"19","author":"Takahashi","year":"2018","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1016\/bs.irn.2023.06.001_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.120078","article-title":"Efficacy and safety of istradefylline in patients with Parkinson\u2019s disease presenting with postural abnormalities: Results from a multicenter, prospective, and open-label exploratory study in Japan","volume":"432","author":"Takahashi","year":"2022","journal-title":"Journal of the Neurological Sciences"},{"issue":"5","key":"10.1016\/bs.irn.2023.06.001_bib19","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1523\/JNEUROSCI.4082-10.2011","article-title":"The distinct role of medium spiny neurons and cholinergic interneurons in the D\u2082\/A\u2082A receptor interaction in the striatum: implications for Parkinson\u2019s disease","volume":"31","author":"Tozzi","year":"2011","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/bs.irn.2023.06.001_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104634","article-title":"Impaired dopamine- and adenosine-mediated signaling and plasticity in a novel rodent model for DYT25 dystonia","volume":"134","author":"Yu-Taeger","year":"2020","journal-title":"Neurobiology of Disease"}],"container-title":["International Review of Neurobiology","Adenosine A2A Receptor Antagonists"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774223000491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774223000491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T14:58:14Z","timestamp":1698677894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774223000491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9780443186677"],"references-count":20,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2023.06.001","relation":{},"ISSN":["0074-7742"],"issn-type":[{"type":"print","value":"0074-7742"}],"subject":[],"published":{"date-parts":[[2023]]}}}